Quebracho Homeopathic Pills Fail Identification Testing
Washington Homeopathic Products is recalling Quebracho homeopathic pills in multiple potencies because testing identified out-of-specification results during identification analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is based on failed identification testing (out-of-specification results), which constitutes a quality/purity concern but without evidence of actual harm. No deaths, hospitalizations, or injuries are documented in the source.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Quebracho homeopathic pills (4C, 5C, 6C, 12C, and 30C potencies) in various package sizes. The recall was initiated due to out-of-specification test results obtained during identification testing using HPTLC (High-Performance Thin Layer Chromatography) analysis.
The affected product lot is #28930 with an expiration date of 8/17/2026. The product was distributed nationwide in the USA and approximately 61 bottles are involved in this recall.
Consumers who have purchased this product should stop using it. Those with questions or concerns are advised to contact the recalling firm, Washington Homeopathic Products, Inc., located at 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
The recalled product
- Product
- Quebracho 4C, 5C, 6C, 12C, 30C, Fever*, Sucrose/Lactose Pills, 5C Packaged as a) 4dr; 6C Packaged as b) 4 Dram UPC 7 40640 44092 6; c) 2 oz UPC 7 40640 44100 8; 12C Packaged as d) 4 Dram; e) 2 oz; 30C Packaged as f) 2 dr UPC 7 40640 44090 2; g) 4 Dram, UPC 7 40640 44094 0; h) 1 o
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- out-of-specification-testing
- identification-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 28930
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27